News & Updates
Filter by Specialty:
Show Multimedia Only
Investigational nasal spray for dry eye disease scores high in phase II trial
16 Aug 2022
The single-dose nicotinic acetylcholine receptor agonist OC-02, administered as an aqueous nasal spray, helps increase tear production and improve eye dryness in patients with dry eye disease (DED), according to data from the phase II PEARL trial.
Investigational nasal spray for dry eye disease scores high in phase II trial
16 Aug 2022
PLWH at a disadvantage in receiving statin therapy for ASCVD risk reduction
16 Aug 2022
People living with HIV (PLWH) are less likely to receive appropriate statin therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD), a study has found.